Actovegin 200 mg 50 tablets
Cerebrolysin 5 ml 5 vials
Sialis 5 mg 14 tablets
Sildenafil 100 mg 20 tablets
Semax nasal drops 0.1% 3 ml
Tamiflu 75 mg 10 capsules
Champix 1 mg 112 tablets
Ingavirin 90 mg 10 capsues
Ovestin 2 mg 30 tablets
Ovestin Vaginal cream 15g
Macmiror 200 mg 20 tablets
Ventolin nebula 20 ampoules
Avodart 0,5 mg 90 capsules
- Antibacterial medication
- Antifungal medication
- Antiviral Medication
- Cardiovascular medication
- different medication
- Hormonal medication
- Immunosuppressants and immunomodulating medications
- Nervous system
- Pain relievers and anti-inflammatory
- Respiratory system
- Treatment of diseases of the liver and gastrointestinal tract
- Treatment of sensory organs, eyesight and hearing
- Urogenital system
De-Nol 120mg 112 tablets
De-Nol 120mg 56 tablets
De-Nol 120mg 32 tablets
finasteride 5mg 30 tablets
Itrazole 100 mg 42 capsules
furasol 15 sachets of 100 mg
Triacort OINTMENT 0.1% 10G
Urseptia 200 mg 20 capsules
Minolexin 100 mg 20 capsules
Minolexin 50 mg 20 capsules
Immard 200 mg 30 tablets
Adenuric 120 mg 28 tablets
Tidomet forte 100 tablets
Cortexin 10 mg 10 vials
Memoplant 80 mg 30 tablets
Actovegin 10 ml 5 vials
Mirapex 1 mg 30 tablets
Pantogam 250 mg 50 tablets
Melaxen 3 mg 12 tablets
Enerion 200 mg 20 tablets
Persen 60 tablets
Persen night 40 capsules
Reminyl 8 mg 7 capsules
Lamolep 25 mg 30 tablets
Axamon 20 mg 50 tablets
Persen 20 tablets
Vinpotropil 60 capsules
Stugeron 25mg 50 tablets
Novo-passit 10 tablets
Mirapex 1.5 mg 30 tablets
Deprim 30 tablets
Mexidol 5 ml 5 vials
Madopar 125 mg 100 capsules
Teraligen 5 mg 25 tablets
Pronoran 50 mg 30 tablets
Cerebrolysin 10 ml 5 vials
Konkor 10 mg 30 tablets
Manufacturer: TAKEDA Pharmaceuticals
Country of origin: Germany
General description: Beta1-blocker
pharmachologic effect
Selective beta-1-adrenoblocker, without its own sympathomimetic activity, does not have a membrane-stabilizing action.
Has only a slight affinity for the β2-adrenoreceptors of the smooth muscles of the bronchi and vessels, as well as to β2-adrenoreceptors involved in the regulation of metabolism. Therefore, bisoprolol as a whole does not affect the resistance of the respiratory tract and the metabolic processes in which β2-adrenergic receptors are involved.
The selective effect of the drug on β1-adrenergic receptors persists beyond the therapeutic range.
Bisoprolol does not have a pronounced negative inotropic effect.
The maximum effect of the drug is achieved 3-4 hours after ingestion. Even with the appointment of bisoprolol 1 time / day, its therapeutic effect persists for 24 hours due to the fact that its T1 / 2 from the blood plasma is 10-12 hours. As a rule, the maximum reduction in BP is achieved 2 weeks after the start of treatment.
Bisoprolol reduces the activity of the sympathoadrenal system by blocking the β1-adrenergic receptors of the heart.
With a single oral intake in patients with IHD without signs of chronic heart failure, bisoprolol reduces heart rate, reduces stroke volume of the heart and, as a result, reduces the ejection fraction and myocardial oxygen demand. With prolonged therapy, the initially increased OPSS decreases. Reduction of renin activity in blood plasma is considered as one of the components of antihypertensive action of beta-blockers.
Indications
- arterial hypertension;
- IHD: stable angina;
Chronic heart failure.


.